Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition
9 May 2026 – 14 May 2026 · Cape Town, South Africa
464-05-001 ISMRM Abstract

Real-World Evidence from 80,000+ Whole-Body MRIs: Application of a Clinically Significant Diagnosis Scale

Accepted
Madhurima Datta1, Yosef Chodakiewitz1, Rodrigo Solis Pompa1, Pratik Shingru1, Vikash Modi1, Amar Patel1, Giuliana Zaccardelli1, Daniel J Durand1, Alex Exuzides1
1Prenuvo, Inc, San Francisco, United States of America
Presenting Author: Sam Hashemi

Synopsis

Motivation:
Goals:
Approach:
Results:
Full abstract & presentation

The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.

Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.

To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.

Log in

References

1. Zugni F, Padhani AR, Koh DM, Summers PE, Bellomi M, Petralia G. “Whole-body magnetic resonance imaging (WB-MRI) for cancer screening in asymptomatic subjects of the general population: review and recommendations.” Cancer Imaging. 2020;20(1):34.doi: 10.1186/s40644-020-00315-0 [doi]
2. Ballinger ML, Best A, Mai PL, et al. Baseline Surveillance in Li-Fraumeni Syndrome Using Whole-Body Magnetic Resonance Imaging: A Meta-analysis. JAMA Oncol. 2017;3(12):1634–1639. doi:10.1001/jamaoncol.2017.1968 [doi]
3. Petralia G, Koh DM, Attariwala R, et al. Oncologically Relevant Findings Reporting and Data System (ONCO-RADS): Guidelines for the Acquisition, Interpretation, and Reporting of Whole-Body MRI for Cancer Screening. Radiology. 2021;299(3):617-628. doi: 10.1148/radiol.2021201740 [doi]

Cite this abstract